Rienk OFFRINGA

Person

Heidelberg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted aminoquinolones as DGKalpha inhibitors for immune activ...
- Patent number 11,998,539
- Issue date Jun 4, 2024
- Bayer Aktiengesellschaft
- Norbert Schmees
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminothiazoles as DGKzeta inhibitors for immune activation
- Patent number 11,964,953
- Issue date Apr 23, 2024
- Bayer Aktiengesellschaft
- Norbert Schmees
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyridine-derivatives
- Patent number 11,427,578
- Issue date Aug 30, 2022
- Bayer Pharma Aktiengesellschaft
- Jeffrey Stuart Mowat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIGEN REACTIVE T-CELL RECEPTORS
- Publication number 20240327911
- Publication date Oct 3, 2024
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Rienk OFFRINGA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240174683
- Publication date May 30, 2024
- Bayer Aktiengesellschaft
- Ulrich LÜCKING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230201186
- Publication date Jun 29, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230167078
- Publication date Jun 1, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230167103
- Publication date Jun 1, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230148194
- Publication date May 11, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230139936
- Publication date May 4, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230064809
- Publication date Mar 2, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230062100
- Publication date Mar 2, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES
- Publication number 20220089721
- Publication date Mar 24, 2022
- Bayer Aktiengesellschaft
- Jrög WILLUDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES
- Publication number 20220047603
- Publication date Feb 17, 2022
- Bayer Aktiengesellschaft
- Jeffrey Stuart MOWAT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMBINATION OF ANTI-CEACAM6 AND EITHER ANTI-PD-1 OR...
- Publication number 20220010017
- Publication date Jan 13, 2022
- Bayer Aktiengesellschaft
- Jörg WILLUDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Pyrrolopyridine-Derivatives
- Publication number 20200246347
- Publication date Aug 6, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Norbert SCHMEES
- C07 - ORGANIC CHEMISTRY

Rienk OFFRINGA

Person

Patents Grantslast 30 patents

Substituted aminoquinolones as DGKalpha inhibitors for immune activ...

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

Substituted pyrrolopyridine-derivatives

Patents Applicationslast 30 patents

ANTIGEN REACTIVE T-CELL RECEPTORS

MAP4K1 INHIBITORS

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES

SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES

PHARMACEUTICAL COMBINATION OF ANTI-CEACAM6 AND EITHER ANTI-PD-1 OR...

Substituted Pyrrolopyridine-Derivatives